Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Onconova Therapeutics Inc (ONTX)
Onconova Therapeutics Inc (ONTX) Financials

ONTX Onconova Therapeutics Inc

0.9953

0.00 (0.00%)

29 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-84.267	-170.793	-179.661	-103.387	-115.24	-42.836	-39.987	-61.068
Return on Equity (%)	-246.346	840.321	751.662	-253.558	-283.475	-61.815	-50.959	-97.217
Return on Invested Capital (%)	-297.558	894.438	821.592	-260.581	-286.515	-63.282	-52.748	-104.148
Operating Margin (%)	-354.364	-3059.593	-1672.15	-984.563	-10888.745	-7151.77	-8391.15	-8384.071
Net Profit Margin (%)	-354.616	-3061.245	-1675.326	-985.021	-10890.476	-7151.77	-8391.15	-8384.071
Book Value Per Share	0.758	-1.008	0.949	0.104	0.033	2.207	1.353	0.508
Earnings Per Share	-2.909	-2.237	-3.626	-0.193	-0.135	-0.773	-0.906	-0.902
Cash Per Share	3.166	0.374	2.991	0.204	0.102	2.635	1.852	0.991
Working Capital Per Share	1.91	-0.471	1.644	0.137	0.053	2.36	1.496	0.64
Operating Profit Per Share	0.82	0.073	0.216	0.02	0.001	0.011	0.011	0.011
EBIT Per Share	-2.907	-2.236	-3.619	-0.193	-0.135	-0.773	-0.906	-0.902
EBITDA Per Share	-2.907	-2.236	-3.619	-0.193	-0.135	-0.773	-0.906	-0.902
Free Cash Flow Per Share	-2.924	-2.245	-3.636	-0.193	-0.135	-0.774	-0.907	-0.902

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	6.76M	10.77M	5.67M	111.17M	185.94M	20.9M	20.93M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	20.93M	20.93M	20.97M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-10312.5	N/A	N/A	N/A	-8898.214	N/A
Net Profit Margin (%)	N/A	N/A	-10312.5	N/A	N/A	N/A	-8898.214	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	20.9M
Price to Earnings Ratio	-5.03
Price to Sales Ratio	420.37
Price to Cash Ratio	4.58
Price to Book Ratio	8.94
Dividend Yield	-

Share Statistics

Shares Outstanding	21M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Onconova Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions